Steady-state PK of omapatrilat in healthy subjects.

被引：8
|
作者：
Delaney, CL [1 ]
Jemal, M [1 ]
Beierle, FA [1 ]
Ferreira, IM [1 ]
Davis, KD [1 ]
Meier, A [1 ]
Ford, NF [1 ]
Uderman, HD [1 ]
Liao, W [1 ]
机构：
[1] Bristol Myers Squibb Pharmaceut Res Inst, Princeton, NJ 08543 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1999年 / 65卷 / 02期
关键词：
D O I：
10.1016/S0009-9236(99)80066-6
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PI66
引用
收藏
页码：133 / 133
页数：1
相关论文
共 50 条
  • [21] THE EFFECTS OF MULTIPLE DOSES OF ROLOFYLLINE ON THE PHARMACODYNAMICS AND PHARMACOKINETICS OF WARFARIN AT STEADY STATE IN HEALTHY SUBJECTS.
    Dishy, V.
    Stroh, M.
    Hwang, E.
    Lazarus-Shipitofsky, N.
    Dittrich, H. C.
    Lai, E.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 : S11 - S11
  • [22] Population pharmacokinetics (PK) of fluticasone propionate (FP) in subjects with asthma, COPD and healthy subjects.
    Mehta, R
    Barnett, V
    Kunka, RL
    Sale, M
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (02) : P64 - P64
  • [23] STEADY-STATE PHARMACOKINETICS AND DOSE-PROPORTIONALITY OF PHENYLPROPANOLAMINE IN HEALTHY-SUBJECTS
    SCHERZINGER, SS
    DOWSE, R
    KANFER, I
    JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 30 (04): : 372 - 377
  • [24] EFFECT OF URAPIDIL ON STEADY-STATE SERUM DIGOXIN CONCENTRATION IN HEALTHY-SUBJECTS
    SOLLEDER, P
    HAERLIN, R
    WURST, W
    KLINGMANN, I
    MOSBERG, H
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 37 (02) : 193 - 194
  • [25] SEX-RELATED DIFFERENCES IN THE STEADY-STATE PHARMACOKINETICS OF PRIMAQUINE IN HEALTHY SUBJECTS
    Binh, Vu Quoc
    Chinh, Nguyen Trong
    Thanh, Nguyen Xuan
    Cuong, Bui Tri
    Quang, Nguyen Ngoc
    Dai, Bui
    Travers, Thomas
    Edstein, Michael D.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2009, 81 (05): : 43 - 43
  • [26] Paracetamol decreases steady-state exposure to lamotrigine by induction of glucuronidation in healthy subjects
    Gastrup, Sandra
    Stage, Tore Bjerregaard
    Fruekilde, Palle Bach Nielsen
    Damkier, Per
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 81 (04) : 735 - 741
  • [27] Pharmacokinetic/pharmacodynamic (PK/PD) model for tolvaptan (TOL) in healthy subjects.
    Van Wart, SA
    Cirincione, BB
    Ludwig, EA
    Chen, X
    Shoaf, S
    Grasela, TH
    Mallikaarjun, S
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) : P60 - P60
  • [28] Effect of Eslicarbazepine Acetate on the Steady-State Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Subjects
    Zummo, Jacqueline
    Vaz-da-Silva, Manuel
    Almeida, Luis
    Falcao, Amilcar
    Versavel, Mark
    Soares, Eva
    Maia, Joana
    Nunes, Teresa
    NEUROLOGY, 2010, 74 (09) : A458 - A458
  • [29] Lack of effect of citalopram on the steady-state pharmacokinetics of carbamazepine in healthy male subjects
    Moller, SE
    Larsen, F
    Khan, AZ
    Rolan, PE
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2001, 21 (05) : 493 - 499
  • [30] Steady-state pharmacokinetic and safety profiles of voriconazole and ritonavir in healthy male subjects
    Liu, Ping
    Foster, Grover
    Gandelman, Kuan
    LaBadie, Robert R.
    Allison, Mark J.
    Gutierrez, Maria J.
    Sharma, Amarnath
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (10) : 3617 - 3626
12345